{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:33:30Z","timestamp":1781134410799,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GrK 2621"],"award-info":[{"award-number":["GrK 2621"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universit\u00e4tsklinik M\u00fcnchen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Antidepressants are first-line medications for many psychiatric disorders. However, their widespread long-term use in some indications (e.g., mild depression and insomnia) is concerning. Particularly in older adults with comorbidities and polypharmacy, who are more susceptible to adverse drug reactions, the risks and benefits of treatment should be regularly reviewed. The aim of this consensus process was to identify explicit criteria of potentially inappropriate antidepressant use (indicators) in order to support primary care clinicians in identifying situations, where deprescribing of antidepressants should be considered.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We used the RAND\/UCLA Appropriateness Method to identify the indicators of high-risk and overprescribing of antidepressants. We combined a structured literature review with a 3-round expert panel, with results discussed in moderated meetings in between rounds. Each of the 282 candidate indicators was scored on a 9-point Likert scale representing the necessity of a critical review of antidepressant continuation (1\u20133\u2009=\u2009not necessary; 4\u20136\u2009=\u2009uncertain; 7\u20139\u2009=\u2009clearly necessary). Experts rated the indicators for the necessity of review, since decisions to deprescribe require considerations of patient risk\/benefit balance and preferences. Indicators with a median necessity rating of\u2009\u2265\u20097 without disagreement after 3 rating rounds were accepted.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The expert panel comprised 2 general practitioners, 2 clinical pharmacologists, 1 gerontopsychiatrist, 2 psychiatrists, and 3 internists\/geriatricians (total <jats:italic>N<\/jats:italic>\u2009=\u200910). After 3 assessment rounds, there was consensus for 37 indicators of high-risk and 25 indicators of overprescribing, where critical reviews were felt to be necessary. High-risk prescribing indicators included settings posing risks of drug-drug, drug-disease, and drug-age interactions or the occurrence of adverse drug reactions. Indicators with the highest ratings included those suggesting the possibility of cardiovascular risks (QTc prolongation), delirium, gastrointestinal bleeding, and liver injury in specific patient subgroups with additional risk factors. Overprescribing indicators target patients with long treatment durations for depression, anxiety, and insomnia as well as high doses for pain and insomnia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Explicit indicators of antidepressant high-risk and overprescribing may be used directly by patients and health care providers, and integrated within clinical decision support tools, in order to improve the overall risk\/benefit balance of this commonly prescribed class of prescription drugs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-024-03397-w","type":"journal-article","created":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:01:53Z","timestamp":1715558513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Deprescribing of antidepressants: development of indicators of high-risk and overprescribing using the RAND\/UCLA Appropriateness Method"],"prefix":"10.1186","volume":"22","author":[{"given":"Vita","family":"Brisnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Vukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Jung-Sievers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoline","family":"Lukaschek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G Caleb","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Thiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Th\u00fcrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelius","family":"Sch\u00fcle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Drey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Harder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelm","family":"Niebling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Janka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Gensichen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Dreischulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the POKAL-Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Falkai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Henningsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"B\u00fchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Krcmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Pitschel-Walz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonius","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Biersack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Eder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feyza","family":"G\u00f6kce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hattenkofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Kaupe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Raub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Reindl-Spanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Schillok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Sch\u00f6nweger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Teusen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"von Schrottenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puya","family":"Younesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,13]]},"reference":[{"issue":"1","key":"3397_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jama.2009.1943","volume":"303","author":"JC Fournier","year":"2010","unstructured":"Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA. 2010;303(1):47\u201353.","journal-title":"JAMA"},{"issue":"2","key":"3397_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4088\/JCP.13m08443","volume":"75","author":"R Mojtabai","year":"2014","unstructured":"Mojtabai R, Olfson M. National trends in long-term use of antidepressant medications: results from the U.S. National Health and Nutrition Examination Survey. J Clin Psychiatry. 2014;75(2):169\u201377.","journal-title":"J Clin Psychiatry"},{"key":"3397_CR3","doi-asserted-by":"publisher","first-page":"l1508","DOI":"10.1136\/bmj.l1508","volume":"364","author":"G Iacobucci","year":"2019","unstructured":"Iacobucci G. NHS prescribed record number of antidepressants last year. BMJ. 2019;364:l1508.","journal-title":"BMJ"},{"key":"3397_CR4","doi-asserted-by":"crossref","unstructured":"Ludwig W, M\u00fchlbauer B, Seifert R. Arzneiverordnungs-Report 2022. Berlin\/Heidelberg: Springer; 2023, p. 347, pp 387\u2013409.","DOI":"10.1007\/978-3-662-66303-5_41"},{"key":"3397_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b3999","volume":"339","author":"M Moore","year":"2009","unstructured":"Moore M, Yuen HM, Dunn N, Mullee MA, Maskell J, Kendrick T. Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database. BMJ. 2009;339: b3999.","journal-title":"BMJ"},{"issue":"604","key":"3397_CR6","doi-asserted-by":"publisher","first-page":"e773","DOI":"10.3399\/bjgp12X658304","volume":"62","author":"CF Johnson","year":"2012","unstructured":"Johnson CF, Macdonald HJ, Atkinson P, Buchanan AI, Downes N, Dougall N. Reviewing long-term antidepressants can reduce drug burden: a prospective observational cohort study. Br J Gen Pract. 2012;62(604):e773\u20139.","journal-title":"Br J Gen Pract"},{"issue":"2","key":"3397_CR7","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/wps.21057","volume":"22","author":"B Arroll","year":"2023","unstructured":"Arroll B, Roskvist R, Moir F, Harwood M, Eggleton K, Dowrick C, et al. Antidepressants in primary care: limited value at the first visit. World Psychiatry. 2023;22(2):340.","journal-title":"World Psychiatry"},{"issue":"1","key":"3397_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1192\/bjp.bp.109.076448","volume":"198","author":"C Barbui","year":"2011","unstructured":"Barbui C, Cipriani A, Patel V, Ayuso-Mateos JL, van Ommeren M. Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis. Br J Psychiatry. 2011;198(1):11\u20136 (sup 1).","journal-title":"Br J Psychiatry."},{"issue":"4","key":"3397_CR9","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1111\/bcp.14564","volume":"87","author":"W Sch\u00e4fer","year":"2021","unstructured":"Sch\u00e4fer W, Reinders T, Riedel O, Haug U. How often are antidepressants prescribed off-label among older adults in Germany? A claims data analysis. Br J Clin Pharmacol. 2021;87(4):1778\u201389.","journal-title":"Br J Clin Pharmacol"},{"key":"3397_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j603","volume":"356","author":"J Wong","year":"2017","unstructured":"Wong J, Motulsky A, Abrahamowicz M, Eguale T, Buckeridge DL, Tamblyn R. Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system. BMJ. 2017;356: j603.","journal-title":"BMJ"},{"key":"3397_CR11","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.2147\/NDT.S241780","volume":"16","author":"C Lunghi","year":"2020","unstructured":"Lunghi C, Antonazzo IC, Burato S, Raschi E, Zoffoli V, Forcesi E, et al. Prevalence and determinants of long-term utilization of antidepressant drugs: a retrospective cohort study. Neuropsychiatr Dis Treat. 2020;16:1157\u201370.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"2","key":"3397_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00127-016-1306-4","volume":"52","author":"B Mars","year":"2017","unstructured":"Mars B, Heron J, Kessler D, Davies NM, Martin RM, Thomas KH, et al. Influences on antidepressant prescribing trends in the UK: 1995\u20132011. Soc Psychiatry Psychiatr Epidemiol. 2017;52(2):193\u2013200.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"5","key":"3397_CR13","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1007\/s11845-021-02833-7","volume":"191","author":"A McCool","year":"2022","unstructured":"McCool A, Lukas K, Hayes P, Kelly D. Antidepressant medication prescribing patterns in Irish general practice from 2016 to 2020 to assess for long-term use. Ir J Med Sci. 2022;191(5):2239\u201346.","journal-title":"Ir J Med Sci"},{"issue":"5","key":"3397_CR14","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000447034","volume":"85","author":"AF Carvalho","year":"2016","unstructured":"Carvalho AF, Sharma MS, Brunoni AR, Vieta E, Fava GA. The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature. Psychother Psychosom. 2016;85(5):270\u201388.","journal-title":"Psychother Psychosom"},{"issue":"6","key":"3397_CR15","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1159\/000480456","volume":"86","author":"KM Huijbregts","year":"2017","unstructured":"Huijbregts KM, Hoogendoorn A, Slottje P, van Balkom A, Batelaan NM. Long-term and short-term antidepressant use in general practice: data from a large cohort in the Netherlands. Psychother Psychosom. 2017;86(6):362\u20139.","journal-title":"Psychother Psychosom"},{"issue":"5","key":"3397_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/YIC.0000000000000393","volume":"37","author":"M D\u00f6rks","year":"2022","unstructured":"D\u00f6rks M, Hoffmann F, Jobski K. Antidepressant drug use and regional prescribing patterns in Germany: results from a large population-based study. International Clinical Psychopharmacology. 2022;37(5):185\u201392.","journal-title":"International Clinical Psychopharmacology."},{"issue":"8","key":"3397_CR17","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/gps.5518","volume":"36","author":"A O\u2019Neill","year":"2021","unstructured":"O\u2019Neill A, McFarland J, Kelly D. Long-term antidepressant use in a cohort of older people. Int J Geriatr Psychiatry. 2021;36(8):1241\u201351.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"3397_CR18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cgh.2014.06.021","volume":"13","author":"HY Jiang","year":"2015","unstructured":"Jiang HY, Chen HZ, Hu XJ, Yu ZH, Yang W, Deng M, et al. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2015;13(1):42-50.e3.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"3397_CR19","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2022.563","volume":"8","author":"N Bansal","year":"2022","unstructured":"Bansal N, Hudda M, Payne RA, Smith DJ, Kessler D, Wiles N. Antidepressant use and risk of adverse outcomes: population-based cohort study. BJPsych Open. 2022;8(5): e164.","journal-title":"BJPsych Open"},{"issue":"4","key":"3397_CR20","first-page":"371","volume":"19","author":"LJ Seppala","year":"2018","unstructured":"Seppala LJ, Wermelink A, de Vries M, Ploegmakers KJ, van de Glind EMM, Daams JG, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: II. Psychotropics J Am Med Dir Assoc. 2018;19(4):371 e11-e17.","journal-title":"Psychotropics. J Am Med Dir Assoc."},{"issue":"6","key":"3397_CR21","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.psym.2014.01.010","volume":"55","author":"L De Picker","year":"2014","unstructured":"De Picker L, Van Den Eede F, Dumont G, Moorkens G, Sabbe BG. Antidepressants and the risk of hyponatremia: a class-by-class review of literature. Psychosomatics. 2014;55(6):536\u201347.","journal-title":"Psychosomatics"},{"issue":"6","key":"3397_CR22","doi-asserted-by":"publisher","first-page":"afad079","DOI":"10.1093\/ageing\/afad079","volume":"52","author":"J Hauff","year":"2023","unstructured":"Hauff J, Rottenkolber M, Oehler P, Fischer S, Gensichen J, Drey M, et al. Single and combined use of fall-risk-increasing drugs and fracture risk: a population-based case-control study. Age Ageing. 2023;52(6):afad079.","journal-title":"Age Ageing."},{"issue":"4","key":"3397_CR23","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s41999-023-00777-y","volume":"14","author":"D O\u2019Mahony","year":"2023","unstructured":"O\u2019Mahony D, Cherubini A, Guiteras AR, Denkinger M, Beuscart JB, Onder G, et al. STOPP\/START criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med. 2023;14(4):625\u201332.","journal-title":"Eur Geriatr Med"},{"key":"3397_CR24","volume-title":"The RAND\/UCLA Appropriateness Method user\u2019s manual","author":"K Fitch","year":"2001","unstructured":"Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR, Lazaro P, et al. The RAND\/UCLA Appropriateness Method user\u2019s manual. Santa Monica, CA: RAND Corporation; 2001."},{"issue":"1","key":"3397_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s40266-017-0514-2","volume":"35","author":"F Pazan","year":"2018","unstructured":"Pazan F, Weiss C, Wehling M. The EURO-FORTA (Fit fOR The Aged) List: international consensus validation of a clinical tool for improved drug treatment in older people. Drugs Aging. 2018;35(1):61\u201371.","journal-title":"Drugs Aging"},{"key":"3397_CR26","doi-asserted-by":"crossref","unstructured":"American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674\u201394.","DOI":"10.1111\/jgs.15767"},{"issue":"31\u201332","key":"3397_CR27","first-page":"543","volume":"107","author":"S Holt","year":"2010","unstructured":"Holt S, Schmiedl S, Th\u00fcrmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int. 2010;107(31\u201332):543\u201351.","journal-title":"Dtsch Arztebl Int"},{"issue":"2","key":"3397_CR28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/afu145","volume":"44","author":"D O\u2019Mahony","year":"2015","unstructured":"O\u2019Mahony D, O\u2019Sullivan D, Byrne S, O\u2019Connor MN, Ryan C, Gallagher P. STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213\u20138.","journal-title":"Age Ageing"},{"issue":"1","key":"3397_CR29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/bcp.14391","volume":"87","author":"WY Khawagi","year":"2021","unstructured":"Khawagi WY, Steinke DT, Nguyen J, Pontefract S, Keers RN. Development of prescribing safety indicators related to mental health disorders and medications: modified e-Delphi study. Br J Clin Pharmacol. 2021;87(1):189\u2013209.","journal-title":"Br J Clin Pharmacol"},{"key":"3397_CR30","first-page":"2015","volume":"5","author":"B DGPPN","year":"2015","unstructured":"DGPPN B, KBV A, Akd\u00c4 B, BApK D, DEGAM D, DGPs D. S3-Leitlinie\/Nationale VersorgungsLeitlinie Unipolare Depression-Langfassung. Auflage Version. 2015;5:2015.","journal-title":"Auflage Version"},{"key":"3397_CR31","unstructured":"Bandelow B, Aden I, Alpers GW, Benecke A, Benecke C, Beutel ME, Deckert J, Domschke K, Eckhardt-Henn A, Geiser F, Gerlach AL, Harfst TH, Hoffmann S, Hoyer J, Hunger-Schoppe C, Kellner M, K\u00f6llner V, Kopp I, Langs G, Liebeck H, Matzat J, Ohly M, R\u00fcddel HP, Rudolf S, Scheufele E, Simon R, Staats H, Str\u00f6hle A, Waldherr B, Wedekind D, Werner AM, Wiltink J, Wolters JP. Deutsche s3-leitlinie behandlung von angstst\u00f6rungen, version 2. AWMF. 2021."},{"issue":"1","key":"3397_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11818-016-0097-x","volume":"21","author":"D Riemann","year":"2017","unstructured":"Riemann D, Baum E, Cohrs S, Cr\u00f6nlein T, Hajak G, Hertenstein E, et al. S3-Leitlinie nicht erholsamer schlaf\/schlafst\u00f6rungen. Somnologie. 2017;21(1):2\u201344.","journal-title":"Somnologie"},{"issue":"1","key":"3397_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s42451-019-00139-8","volume":"3","author":"T Schlereth","year":"2020","unstructured":"Schlereth T. S2k-leitlinie: diagnose und nicht interventionelle Therapie neuropathischer Schmerzen. DGNeurologie. 2020;3(1):21\u201340.","journal-title":"DGNeurologie"},{"issue":"5","key":"3397_CR34","doi-asserted-by":"publisher","first-page":"e0217406","DOI":"10.1371\/journal.pone.0217406","volume":"14","author":"WY Khawagi","year":"2019","unstructured":"Khawagi WY, Steinke DT, Nguyen J, Keers RN. Identifying potential prescribing safety indicators related to mental health disorders and medications: a systematic review. PLoS ONE. 2019;14(5):e0217406.","journal-title":"PLoS ONE"},{"key":"3397_CR35","doi-asserted-by":"publisher","unstructured":"Bundes\u00e4rztekammer (B\u00c4K), Kassen\u00e4rztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Chronische Herzinsuffizienz \u2013 Langfassung, 3. Auflage. Version 3. 2019 [cited: 2023-09-10]. https:\/\/doi.org\/10.6101\/AZQ\/000482.","DOI":"10.6101\/AZQ\/000482"},{"issue":"9","key":"3397_CR36","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1177\/014107680009300903","volume":"93","author":"J Mintzer","year":"2000","unstructured":"Mintzer J, Burns A. Anticholinergic side-effects of drugs in elderly people. J R Soc Med. 2000;93(9):457\u201362.","journal-title":"J R Soc Med"},{"issue":"8","key":"3397_CR37","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1177\/0269881113492027","volume":"27","author":"E Whiskey","year":"2013","unstructured":"Whiskey E, Taylor D. A review of the adverse effects and safety of noradrenergic antidepressants. J Psychopharmacol. 2013;27(8):732\u20139.","journal-title":"J Psychopharmacol"},{"issue":"3","key":"3397_CR38","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3390\/neurolint13030038","volume":"13","author":"AN Edinoff","year":"2021","unstructured":"Edinoff AN, Akuly HA, Hanna TA, Ochoa CO, Patti SJ, Ghaffar YA, et al. Selective serotonin reuptake inhibitors and adverse effects: a narrative review. Neurol Int. 2021;13(3):387\u2013401.","journal-title":"Neurol Int"},{"issue":"5","key":"3397_CR39","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s40266-023-01024-6","volume":"40","author":"F Pazan","year":"2023","unstructured":"Pazan F, Weiss C, Wehling M. The EURO-FORTA (Fit fOR The Aged) List version 2: consensus validation of a clinical tool for improved pharmacotherapy in older adults. Drugs Aging. 2023;40(5):417\u201326.","journal-title":"Drugs Aging"},{"issue":"1","key":"3397_CR40","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/07853890.2021.2017474","volume":"54","author":"S Nochaiwong","year":"2022","unstructured":"Nochaiwong S, Ruengorn C, Awiphan R, Chai-Adisaksopha C, Tantraworasin A, Phosuya C, et al. Use of serotonin reuptake inhibitor antidepressants and the risk of bleeding complications in patients on anticoagulant or antiplatelet agents: a systematic review and meta-analysis. Ann Med. 2022;54(1):80\u201397.","journal-title":"Ann Med"},{"issue":"8","key":"3397_CR41","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.hlc.2019.07.011","volume":"29","author":"G Mawardi","year":"2020","unstructured":"Mawardi G, Markman TM, Muslem R, Sobhanian M, Converse M, Meadows HB, et al. SSRI\/SNRI therapy is associated with a higher risk of gastrointestinal bleeding in LVAD patients. Heart Lung Circ. 2020;29(8):1241\u20136.","journal-title":"Heart Lung Circ"},{"issue":"1","key":"3397_CR42","doi-asserted-by":"publisher","first-page":"14452","DOI":"10.1038\/s41598-022-18654-2","volume":"12","author":"SM Alam","year":"2022","unstructured":"Alam SM, Qasswal M, Ahsan MJ, Walters RW, Chandra S. Selective serotonin reuptake inhibitors increase risk of upper gastrointestinal bleeding when used with NSAIDs: a systemic review and meta-analysis. Sci Rep. 2022;12(1):14452.","journal-title":"Sci Rep"},{"issue":"4","key":"3397_CR43","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/ageing\/afaa249","volume":"50","author":"LJ Seppala","year":"2021","unstructured":"Seppala LJ, Petrovic M, Ryg J, Bahat G, Topinkova E, Szczerbi\u0144ska K, et al. STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk): a Delphi study by the EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs. Age Ageing. 2021;50(4):1189\u201399.","journal-title":"Age Ageing"},{"issue":"1\u20132","key":"3397_CR44","first-page":"3","volume":"120","author":"NK Mann","year":"2023","unstructured":"Mann NK, Mathes T, S\u00f6nnichsen A, Pieper D, Klager E, Moussa M, et al. Potentially inadequate medications in the elderly: PRISCUS 2.0. Dtsch Arztebl Int. 2023;120(1\u20132):3\u201310.","journal-title":"Dtsch Arztebl Int."},{"issue":"1","key":"3397_CR45","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12875-022-01913-6","volume":"23","author":"J Gensichen","year":"2022","unstructured":"Gensichen J, Lukaschek K, Jung-Sievers C, Falkai P, Schmitt A, Henningsen P, et al. Predictors and outcomes in primary depression care (POKAL) \u2013 a research training group develops an innovative approach to collaborative care. BMC Primary Care. 2022;23(1):309.","journal-title":"BMC Primary Care"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-024-03397-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-024-03397-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-024-03397-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:02:08Z","timestamp":1715558528000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-024-03397-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,13]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3397"],"URL":"https:\/\/doi.org\/10.1186\/s12916-024-03397-w","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,13]]},"assertion":[{"value":"12 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not require ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"193"}}